H.R. 3668 (112th): Counterfeit Drug Penalty Enhancement Act of 2012

Introduced:
Dec 14, 2011 (112th Congress, 2011–2013)
Sponsor:
Rep. Patrick Meehan [R-PA7]
Status:
Died (Passed House)

The bill’s title was written by the bill’s sponsor. H.R. stands for House of Representatives bill.

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.


6/18/2012--Passed House amended.
Counterfeit Drug Penalty Enhancement Act of 2012 - Amends the federal criminal code to prohibit and to establish criminal penalties for trafficking, or attempting to traffic, in counterfeit drugs.
Directs:
(1) the Attorney General to give increased priority to efforts to investigate and prosecute offenses that involve trafficking in counterfeit drugs; and
(2) the United States Sentencing Commission to review and, if appropriate, amend its guidelines and policy statements applicable to persons convicted of such offense to reflect congressional intent that penalties be increased to reflect the serious nature of such offense and the need for an effective deterrent and to account for the resulting harm to the public.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.


This summary can be found at http://www.gop.gov/bill/112/2/hr3668.

Background

According to the House Committee on the Judiciary, Rep. Pat Meehan introduced the bill to increase criminal penalties for the trafficking of counterfeit drugs.

Current law prohibits trafficking in counterfeit goods.  This statute is primarily concerned with goods that are trafficked using counterfeit marks or labeling.  However, counterfeit drugs are more serious.  Counterfeit drugs present a real health risk to consumers, not merely a financial loss to the manufacturer or mark holder.  While current law technically includes counterfeit drugs, the law does not expressly prohibit trafficking in counterfeit drugs and carries a maximum penalty of only 10 years.

In late February 2012, drug manufacturer Roche announced that a counterfeit form of the cancer drug Avastin had been imported and distributed to doctors in the U.S.  The counterfeit versions of the drug contain a variety of chemicals, ranging from starch and salt to solvent chemicals like acetone, but not the active ingredient found in the genuine drug.

According to the Washington Post, “British regulators have confirmed that 41 vials of fake Avastin were shipped to the U.S.  Five have been recovered while 36 which are still missing.  Authorities in Europe have traced the counterfeit product back through distributors in Britain, Denmark and Switzerland. The original country of origin is still unclear.”

“Experts say gauging harm from a counterfeit cancer treatment is very difficult because drug infusions are spaced out over weeks and months. A colon cancer patient, for example, might receive 18 to 20 Avastin infusions over six months. Missing one dose seems unlikely to have a dramatic effect on survival odds, but it’s not provable either way.”

Even with a 10 year maximum penalty, the actual sentences imposed under the existing counterfeit goods statute are dramatically lower.  According to the U.S. Sentencing Commission, between FY 2006 and FY 2010, there were 385 federal prosecutions for counterfeit goods (18 U.S.C. § 2320).  The median sentence was 17 months; the mean sentence was only 10 months.

Summary

H.R. 3668 would amend the federal criminal code to establish criminal penalties of a fine, imprisonment for no more than 20 years, or both, for trafficking in counterfeit drugs.  The bill would state that nothing in the Act shall be construed to apply to a drug solely because the drug is manufactured in or imported from a foreign country.

Cost

There was no CBO score at press time.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

The bill contains the following citations to other parts of U.S. law:

United States Code

The United States Code is the compilation of permanent laws enacted by Congress. Temporary and other non-permanent laws do not appear in the United States Code. (About half of the United States Code is the law itself, called positive law. The other half is merely a compilation of the laws but has no legal significance.)